Division of Gastroenterology and Hepatology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Department of Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Aliment Pharmacol Ther. 2024 Oct;60(8):1087-1109. doi: 10.1111/apt.18221. Epub 2024 Aug 26.
The incidence of hospitalisations related to acute-on-chronic liver failure (ACLF) is increasing. Liver transplantation (LT) remains the definitive treatment for the condition.
To evaluate the influence of race and ethnicity on LT outcomes in ACLF.
We conducted a retrospective analysis utilising LT data from the United Network for Organ Sharing (UNOS) database. White patients served as the control group and patients of other races were compared at each ACLF grade. The primary outcomes assessed were graft failure and all-cause mortality.
Blacks exhibited a higher all-cause mortality (Grade 1: aHR 1.36, 95% CI 1.18-1.57, p < 0.001; Grade 2: aHR 1.27, 95% CI 1.08-1.48, p = 0.003; Grade 3: aHR 1.19, 95% CI 1.04-1.37, p = 0.01) and graft failure (Grade 1: aHR 2.05, 95% CI 1.58-2.67, p < 0.001; Grade 2: aHR 1.91, 95% CI 1.43-2.54, p < 0.001; Grade 3: aHR 1.50, 95% CI 1.15-1.96, p = 0.002). Hispanics experienced a lower all-cause mortality at grades 1 and 3 (Grade 1: aHR 0.83, 95% CI 0.72-0.96, p = 0.01; Grade 3: aHR 0.80, 95% CI 0.70-0.91, p < 0.001) and Asians with severe ACLF demonstrated decreased all-cause mortality (Grade 3: aHR 0.55, 95% CI 0.42-0.73, p < 0.001).
Black patients experienced the poorest outcomes and Hispanic and Asian patients demonstrated more favourable outcomes compared to Whites.
与慢加急性肝衰竭(ACLF)相关的住院发病率正在上升。肝移植(LT)仍然是该疾病的明确治疗方法。
评估种族和民族对 ACLF 患者 LT 结局的影响。
我们利用美国器官共享网络(UNOS)数据库中的 LT 数据进行了回顾性分析。白人患者作为对照组,在每个 ACLF 等级下比较其他种族的患者。评估的主要结局是移植物失败和全因死亡率。
黑人的全因死亡率更高(等级 1:aHR 1.36,95%CI 1.18-1.57,p<0.001;等级 2:aHR 1.27,95%CI 1.08-1.48,p=0.003;等级 3:aHR 1.19,95%CI 1.04-1.37,p=0.01)和移植物失败(等级 1:aHR 2.05,95%CI 1.58-2.67,p<0.001;等级 2:aHR 1.91,95%CI 1.43-2.54,p<0.001;等级 3:aHR 1.50,95%CI 1.15-1.96,p=0.002)。西班牙裔在等级 1 和 3 时全因死亡率较低(等级 1:aHR 0.83,95%CI 0.72-0.96,p=0.01;等级 3:aHR 0.80,95%CI 0.70-0.91,p<0.001),而严重 ACLF 的亚裔患者全因死亡率降低(等级 3:aHR 0.55,95%CI 0.42-0.73,p<0.001)。
黑人患者的预后最差,而西班牙裔和亚裔患者的预后比白人患者更有利。